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Abstract: Wheat aleurone, due to its potentially higher bioaccessibility and bioavailability of
micronutrients and phenolic acids, could represent a useful ingredient in the production of
commonly consumed cereal-based food. The aim of the present study was to investigate the in vitro
bioaccessibility of phenolic acids both from an aleurone-enriched bread and from a whole grain bread.
The two bread samples were firstly characterized for the phenolic acid content. An in vitro digestion
was then performed in order to evaluate the release of phenolic acids. The results obtained suggest
that the bioaccessibility of the phenolic acids in the aleurone-enriched bread is higher than in the
whole grain bread. These in vitro results suggest the potential use of aleurone in the production of
foods, and this may represent an attractive possibility to vehicle nutritionally interesting components
to consumers.
Keywords: ferulic acid; whole grain bread; aleurone; bioaccessibility
1. Introduction
Mounting evidence indicates that diets rich in whole grain products contribute to a reduced risk
of developing chronic degenerative diseases, such as cardiovascular disease, type 2 diabetes, and
some cancers, and they may also play a role in body weight management and digestive health [1–7].
The worldwide dietary guidelines recommend replacing refined products with an increased whole
grain cereal intake [5]. Despite the growing awareness about the health effects associated with the
consumption of whole grain products, the consumption of whole grain products is much lower than
the recommended intake in many Western countries [8].
Consumer concerns about sensory quality represents the main cause of the poor intake of whole
grain foods, making efforts aimed at overcoming this perception of paramount importance [9].
New technologies allow for the isolation and reincorporation of different specific fractions of the
cereal kernel in food recipes, with the objective of producing foods with the nutritional characteristics
of whole grain, but with the appearance and taste of refined grain products [10]. This could represent
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a major step to encourage and increase the consumption of whole grain products. To this end, wheat
aleurone has been proposed as a nutritionally-rich fraction for cereal-based food production [11].
Wheat aleurone is a part of the kernel, composed of a single layer of cells. It constitutes 6%–9%
of the dry mass of the grain and is anatomically located between the starchy endosperm and the
outer husks [12]. The aleurone comprises a layer of cells covering the surface of the endosperm and
its biological function includes the accumulation and mobilization of nutrients during development
and germination of the seed [13]. Although the aleurone layer is botanically considered to be a part
of the endosperm, it is usually removed together with the outer fractions of the wheat during the
milling process, being strongly attached to the hyaline layer, and it is usually recovered in the bran.
Wheat aleurone is an important source of fiber and, due to its biological role of nutrient stock for the
kernel, it is also particularly rich in high quality protein, lipids (such as plant sterols), B vitamins,
minerals, and phytochemical compounds such as phenolic acids [11]. The main phenolic acids in
wheat aleurone are the hydroxycinnamic acids [11], including ferulic acid, which has been described
being the most abundant and, possibly, one of the major contributors to the beneficial effects associated
to whole grain consumption [14]. Ferulic acid occurs mainly as dimers (diferulates) covalently bound
to arabinoxylans [15], and it has an important role in the structural properties of aleurone fiber fraction.
However, it is this structural characteristic that may affect the bioavailability of ferulic acid and other
phenolic compounds in this matrix [16]. Recently, an increased in vitro bioaccessibility of phenolic
acids and vitamins from two isolated aleurone fractions, when compared with the unfractionated bran
conventionally used in the production of wholemeal products, has been described by our group [17].
The bioavailability of hydroxycinnamates from the same isolated wheat aleurone fractions was also
investigated in vivo, confirming an increased 24-h excretion of phenolic metabolites/catabolites, mainly
ferulic acid, in rats fed with wheat aleurone-rich pellets compared to the regular control diet [18].
Consequently, aleurone could represent a beneficial ingredient in production of cereal-based food.
The aim of the present work was to investigate the in vitro bioaccessibility of phenolic acids, both
from an aleurone-enriched bread and from a whole grain bread.
2. Experimental Section
2.1. Bread Samples
Both the test commercial aleurone-enriched sliced bread (“Pan Bauletto Fior di Fibra”) and
whole grain sliced bread (“Pan Bauletto Integrale”) were provided by Barilla S.p.A. The test bread is
industrially produced by enriching common wheat (T. aestivum) flour with an aleurone-rich fraction
obtained from durum wheat (T. turgidum var. durum). The aleurone fraction was previously described
by Zaupa et al. [17] as aleurone A or inner part of aleurone (IN), and was subsequently used for the rats
feeding in the work of Calani et al. [18] as aleurone A (WA-A). The ingredients of the aleurone-enriched
bread (“Pan Bauletto Fior di Fibra”) were: common wheat flour (0 type, moistureď 14.50%, ash ď 0.65%
DW (dry weight), and protein ď 11% DW, as regulated by Italian DPR 187/2001), water, aleurone-rich
fraction (9.3%), extra virgin olive oil (3.9%), yeast, wheat gluten, salt, sugar, barley flour. The total
extraction rate of the two flours used for the production of aleurone-rich bread (common wheat flour
and aleurone-rich fraction) was 88%–90%. The ingredients of the commercial whole grain bread
were: whole grain flour from common wheat (64.2%), water, sunflower oil (4.3%), wheat gluten, yeast,
dextrose, salt, and barley flour. The extraction rate of the whole grain bread corresponded to 95%–99%.
The nutrient composition of the two breads is described in Table 1.
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Table 1. Nutrient composition of the two breads.
Mean Value (100 g) Whole Grain Bread Aleurone-Enriched Bread
Energy (kcal) 262 261
Energy (kJ) 1101 1101
Fats (g) 5.8 4.2
Carbohydrates (g) 37.5 43.3
Fiber (g) 8.0 6.0
Proteins (g) 10.9 9.5
2.2. Chemicals
Ferulic acid, p-coumaric acid, caffeic acid, sinapic acid, pepsin from porcine gastric mucosa,
pancreatin from porcine pancreas (3 ˆ USP), and all the chemicals used in this study were purchased
from Sigma-Aldrich (Steinheim, Germany). Spectra/Por® dialysis membrane tubes were from
Spectrum® Laboratories Inc. (Rancho Dominguez, CA, USA).
2.3. In Vitro Digestion
The in vitro digestion of the breads was performed following the method of Zaupa et al. [17].
Three slices of each bread were minced using a household chopper (La Moulinette, Moulinex, France)
and 8 g of sample were suspended in 5 mL of preheated (37 ˝C) phosphate buffer (20 mM) NaCl 10 mM
(pH 6.9) and 25 mL of NaCl (0.9%) with 1.5 mL human saliva for 2 min. The saliva was collected
from three non-smoker adult donors after thorough tooth brushing and abstinence from food and
drink (except water) for at least 1 h before the experiment. The pH was then adjusted to 2.0–2.5
using HCl 8 M. Samples were then incubated at 37 ˝C for 2 h after the addition of 1 mL solution of
NaCl (0.9%) dissolved porcine pepsin (2500 U) to mimic the gastric phase. For the intestinal step,
the pH was modified to 6.9 with 5 M NaOH and each sample transferred into 20 cm dialysis tubing
strips (final volume: 50 mL; 12,000–14,000 Da molecular weight cut-off) with 100 mg of pancreatin
from porcine pancreas (3 ˆ USP), sealed with plastic clamps, and incubated at 37 ˝C in a Dubnoff
bath (ISCO, Milan, Italy), shaken at 200 rpm for 24 h into 1000 mL sealed containers with 450 mL of
phosphate buffer. After 24 h of digestion dialysis, all the retained samples (inside tube/undigested
sample) were stored at ´20 ˝C prior to analysis. All in vitro digestions were performed in triplicate for
each bread sample.
The bioaccessibility of each phenolic compound was expressed using the following calculation:
ppAmount before digestion´ amount in residue after digestionq{Amount before digestionqˆ 100
2.4. Extraction of Phenolic Acids
Extraction of phenolic compounds from both fresh bread samples and fractions retained within the
dialysis tube after digestion was performed following method of Zaupa et al. [17]. For the determination
of free phenolic acids, 50 mg of sample were extracted with 6 mL of water under agitation for 20 min
at room temperature, followed by centrifugation at 9200ˆ g for 10 min, after which the supernatant
was collected and stored at ´20 ˝C. For the extraction of bound phenolic compounds, the residue was
further hydrolyzed with 1.5 mL of 2 M sodium hydroxide at room temperature for 1 h. After alkaline
hydrolysis, the pH of the mixture was adjusted to 3 by adding 1.35 mL of 3 M citric acid. The bound
phenolic samples were then extracted with 6 mL of ethyl acetate. The ethyl acetate extracts were
evaporated to dryness in vacuo, the residue dissolved in methanol and stored at´20 ˝C. All the extracts
were filtered with 0.45 µm nylon filters prior to UHPLC-MSn analysis. The extractions were performed
in triplicate for each fresh bread sample. Each undigested sample originating from the triplicate
digestive process was extracted in duplicate, generating six extracts for phenolic analyses.
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2.5. LC-MSn Analyses
Phenolic acids in breads and undigested samples were analyzed using an Accela UHPLC 1250
equipped with linear ion-trap-mass spectrometer (LTQ XL, Thermo Fisher Scientific Inc., San Jose,
CA, USA) fitted with a heated-electrospray ionization probe (H-ESI-II; Thermo Fisher Scientific Inc.).
Separation was carried out by means of a C18 BlueOrchid column (50 ˆ 2 mm; 1.8 µm particle size;
Knauer, Berlin, Germany). The phenolic acids analysis was carried out in negative ionization mode,
using the following conditions. The MS worked with a capillary temperature of 275 ˝C, while the
source heather temperature was set to 45 ˝C. The sheath gas flow was 40 units, while auxiliary and
sweep gases were set to 5 and 2 units, respectively. The source voltage was 4 kV. The capillary voltage
and tube lens were ´21.00 and ´57.71 V, respectively. For separation of the analytes, phase A was
aqueous formic acid (0.1%, v:v) and phase B was methanol/water (98:2, v:v). The mobile phase,
pumped at a flow rate of 0.2 mL/min, was a 12 min linear gradient of 7% to 50% of B. Then, phase
B turned up to 80% and kept for 3 min, followed by 5 min of re-equilibration time at the starting
conditions. Analyses were carried out using selected reaction monitoring (SRM); p-coumaric acid
(m/z 163) was fragmented using pure helium (99.999%) with a collision-induced dissociation (CID)
equal to 30, generating the corresponding fragment ion at m/z 119; caffeic acid (m/z 179) yielded
the corresponding fragment ion at m/z 135, using a CID of 29; ferulic acid (m/z 193) generated three
daughter ions at m/z 134, 149, and 178, using a CID of 28; sinapic acid (m/z 223) generated three
fragment ions at m/z 164, 179, and 208, with a CID of 25. The quantification of each phenolic acid was
performed through a calibration curve with the respective commercial standard. Dimeric and trimeric
ferulic acids with respective [M ´ H]´ values of m/z 385 and 577 were analyzed in full-scan MS2
mode and quantified as ferulic acid equivalents because of unavailability of equivalent commercial
standards. Each individual sample was analyzed in duplicate. Results were expressed as milligrams
per 100 grams of sample on a dry weight basis (mg/100 g DW).
2.6. Statistical Analysis
Data are expressed as means and standard deviation (SD). The t test for independent samples
(p < 0.05) was used to identify differences between the two breads, using SPSS Version 19.0 statistical
software (SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Characterization and Quantification of Phenolic Profile
The phenolic profile of the two breads, including mass characteristics of each identified compound,
is reported in Table 2. Caffeic, p-coumaric, ferulic, sinapic acid, and dimers and trimers of ferulic acid
were identified as the most representative phenolics in the samples. The identification was based on the
mass-to-charge ratio (m/z) of the molecular ion and on characteristic fragment ions. Comparison with
authentic standards was performed whenever possible. The quantification of phenolic acids detected in
each bread is reported in Table 3. The identified phenolic acids are mainly present as bound to the fiber
both in aleurone-enriched and whole grain breads. Monomeric ferulic acid and its oligomers represent
the main contributors to the total phenolic content in the two matrices, ranging from 144.8 mg/100 g
DW (dry weight) for whole grain bread to 70.7 mg/100 g DW for the aleurone-enriched bread, also in
accordance with the fiber content, which is higher in whole grain bread with respect to the test bread
(Table 1). As expected, among the free phenolics, ferulic acid was the main identified compound, with
a concentration of 0.71 and 0.41 mg/100 g DW in whole grain bread and aleurone-enriched bread,
respectively, while bound ferulic acid mostly occurred as dimers in both bread samples (Table 3).
Among the other detected and quantified phenolics, sinapic, p-coumaric acid, and caffeic acids were
also present in relevant concentrations (5.43 and 5.11 mg/100 g DW in total for whole grain and
aleurone-enriched breads, respectively).
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Table 2. Mass spectral characteristics of phenolic compounds identified in bread samples.
Compound RT (min) [M ´ H]´ (m/z) MS2 Ions (m/z)
p-Coumaric acid 9.18 163 119
Caffeic acid 7.38 179 135
Ferulic acid 10.06 193 149, 178, 134
Sinapic acid 10.43 223 208, 179, 164
Dimeric ferulic acid 10.21 385 341, 249, 317
Dimeric ferulic acid 11.56 385 341, 297, 317, 249
Dimeric ferulic acid 13.70 385 341, 317, 249, 297
Dimeric ferulic acid 14.27 385 341, 317, 249
Trimeric ferulic acid 13.65 577 441, 509, 533, 489, 341
Trimeric ferulic acid 15.42 577 533, 441, 509
Table 3. Phenolic acids in bread samples. Data are expressed both as content (mg/100 g DW,
mean ˘ SD of 6 replicates) and as percentage contribution of individual phenolic acids to the
total content.
Whole Grain Bread Aleurone-Enriched Bread
Free Compounds mg/100 g DW % mg/100 g DW %
p-Coumaric acid 0.02 ˘ 0.02 2.6 0.05 ˘ 0.01 8.3 *
Caffeic acid 0.04 ˘ 0.02 5.2 0.02 ˘ 0.01 3.3 *
Sinapic acid nd 0.12 ˘ 0.02 20.0
Ferulic acid 0.71 ˘ 0.16 92.2 0.41 ˘ 0.04 68.3 *
Dimeric ferulic acid nd nd
Dimeric ferulic acid nd nd
Dimeric ferulic acid nd nd
Dimeric ferulic acid nd nd
Trimeric ferulic acid nd nd
Trimeric ferulic acid nd nd
Bound compounds mg/100 g DW % mg/100 g DW %
p-Coumaric acid 1.49 ˘ 0.40 1.0 0.82 ˘ 0.06 1.1 *
Caffeic acid 0.79 ˘ 0.16 0.5 0.26 ˘ 0.01 0.3 *
Sinapic acid 3.08 ˘ 0.71 2.1 3.84 ˘ 0.51 5.1 *
Ferulic acid 57.88 ˘ 11.78 38.7 28.46 ˘ 1.54 37.9 *
Dimeric ferulic acid 5.33 ˘ 0.72 3.6 2.66 ˘ 0.20 3.5 *
Dimeric ferulic acid 9.04 ˘ 1.71 6.0 4.07 ˘ 0.36 5.4 *
Dimeric ferulic acid 4.73 ˘ 0.83 3.2 2.35 ˘ 0.53 3.1 *
Dimeric ferulic acid 59.16 ˘ 15.25 39.6 29.64 ˘ 3.42 39.4 *
Trimeric ferulic acid 1.25 ˘ 0.69 0.8 nd
Trimeric ferulic acid 6.67 ˘ 1.62 4.5 3.08 ˘ 0.73 4.1 *
Total free + bound mg/100 g DW % mg/100 g DW %
p-Coumaric acid 1.51 ˘ 0.42 1.0 0.87 ˘ 0.07 1.1 *
Caffeic acid 0.83 ˘ 0.18 0.6 0.28 ˘ 0.02 0.4 *
Sinapic acid 3.08 ˘ 0.71 2.1 3.96 ˘ 0.52 5.2 *
Ferulic acid 58.59 ˘ 11.90 39.0 28.87 ˘ 1.55 38.1 *
Dimeric ferulic acid 78.27 ˘ 17.54 52.1 38.72 ˘ 3.53 51.1 *
Trimeric ferulic acid 7.92 ˘ 2.06 5.3 3.08 ˘ 0.73 4.1 *
Total (ferulic acid +
dimeric ferulic acids +
trimeric ferulic acids)
mg/100 g DW mg/100 g DW
Total ferulic acid 144.78 ˘ 31.04 70.67 ˘ 4.71 *
* Significant differences between the two breads (p < 0.05); nd, not detected.
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3.2. Bioaccessibility of Phenolic Acids in Bread Samples
Figure 1 illustrates the bioaccessibility of phenolic compounds after in vitro digestion. The results
describe the percentage of phenolic acids released through the dialysis membrane during in vitro
digestion with respect to the total phenolic content of the samples. The bioaccessibility of the four
phenolic acids (p-coumaric acid, caffeic acid, ferulic acid monomers, dimers, trimers, and sinapic acid)
was significantly higher from aleurone-rich bread than the whole grain bread (Figure 1). Among the
phenolic acids, caffeic and sinapic acids appeared as the most bioaccessible both in aleurone-rich and
whole grain breads, while total ferulic acid and p-coumaric acid were less bioaccessible.
Nutrients 2016, 8, 42 6 of 9 
vitro digestion with respect to the t tal phenolic content of the samples. The bioaccessibility of the 
four phenolic acids (p- oumaric acid, caffe  acid, ferulic acid monomers, dim r , tr mers, and 
sinapic ac d) wa  significantly higher rom aleurone-rich bread than the whole grain bread (Figure 1). 
Among the phenolic acids, caffeic and sinapic acids ppeared as the most bioaccessible both in 
aleuro e-rich and whole grai  breads, whil  total ferulic acid nd p-coumaric acid were less 
bioaccessible. 
 
Figure 1. Bioaccessibility (%) of the detected phenolic acids in the two breads (mean ± SD, n = 12). * 
Significant differences between the two breads (p < 0.05). Δ, difference of bioaccessibility between the 
two breads. 
4. Discussion 
This study investigated the in vitro bioaccessibility of phenolic acids from a commercial bread 
produced with a selected aleurone fraction, compared with a whole grain bread. The aleurone 
fraction used for the production of the test bread, and named aleurone flour in previously published 
works [17,18], does not correspond to a specific histological separation as it was obtained through an 
industrial process. 
As expected, the majority of phenolic compounds have been found to be bound to the fiber, 
with ferulic acid representing the main phenolic acid present in both commercial breads. The content 
of phenolic compounds is higher in whole grain bread than in aleurone-enriched bread, in 
accordance with fiber content (Table 1). The in vitro digestion of the two breads showed a 
significantly higher bioaccessibility of the four main phenolic acids detected in the 
aleurone-enriched bread with respect to the commercial whole grain bread, confirming the 
previously reported higher bioaccessibility of phenolics [17] and of antioxidant capacity [19] after in 
vitro digestion of durum wheat aleurone compared to the unfractionated bran that is commonly 
used for wholemeal products. In very good agreement with previous data, the bioaccessibility of 
ferulic acid from the aleurone flour was estimated to be around 30% [17], the same value obtained 
for the aleurone-enriched bread analyzed in the present study. This result suggests that phenolic 
acids maintain the high bioaccessibility they have shown in aleurone fraction even when aleurone 
fraction flour is incorporated into bread. In a recent bioavailability study carried out in an animal 
model, the same aleurone fraction used for the production of the test bread analyzed in the present 
study has been fed to rats. Several phenolic metabolites, derived from the hepatic and microbial 
metabolism of wheat phenolics, were found at relevant concentrations in 24 h-urine samples after 
 
Figure 1. Bioaccessibility (%) of the detected phenolic acids in the two breads (mean ˘ SD, n = 12).
* Significant differences between the two breads (p < 0.05). ∆, difference of bioaccessibility between the
two breads.
4. Discussion
This study investigated the in vitro bioaccessibility of phenolic acids from a commercial bread
produced with a selected aleurone fraction, compared with a whole grain bread. The aleurone
fraction used for the production of the test bread, and named aleurone flour in previously published
works [17,18], does not correspond to a specific histological separation as it was obtained through an
industrial process.
As expected, the majority of phenolic compounds have been found to be bound to the fiber, with
ferulic acid representing the main phenolic acid present in both commercial breads. The content of
phenolic compounds is higher in whole grain bread than in aleurone-enriched bread, in accordance
with fiber content (Table 1). The in vitro digestion of the two breads showed a significantly higher
bioaccessibility of the four main phenolic acids detected in the aleurone-enriched bread with respect
to the commercial whole grain bread, confirming the previously reported higher bioaccessibility
of phenolics [17] and of antioxidant capacity [19] after in vitro digestion of durum wheat aleurone
compared to the unfractionated bran that is commonly used for wholemeal products. In very good
agreement with previous data, the bioaccessibility of ferulic acid from the aleurone flour was estimated
to be around 30% [17], the same value obtained for the aleurone-enriched bread analyzed in the
present study. This result suggests that phenolic acids maintain the high bioaccessibility they have
shown in aleurone fraction even when aleurone fraction flour is incorporated into bread. In a recent
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bioavailability study carried out in an animal model, the same aleurone fraction used for the production
of the test bread analyzed in the present study has been fed to rats. Several phenolic metabolites,
derived from the hepatic and microbial metabolism of wheat phenolics, were found at relevant
concentrations in 24 h-urine samples after both acute and chronic feedings, suggesting that aleurone
fraction phenolics are actually bioavailable and not just bioaccessible [18].
In general, wholemeal products have been previously described as rich in phenolic compounds
(mainly hydroxycinnamates), but these compounds have been described as scarcely bioaccessible
and bioavailable [20,21]. Indeed, although the whole grain bread analyzed in this work provided
higher levels of phenolics and fiber than its aleurone-enriched counterpart, the significantly higher
bioaccessibility of phenolics in the latter would ideally contribute to a higher level of circulating
phenolic metabolites in vivo. This fact, associated with the higher amount of micronutrients, such as
minerals and B vitamins, as reported by Zaupa et al. [17], makes the aleurone-enriched product the
best choice from a nutritional viewpoint. Thus, the results of the present study, adding to previous
evidence obtained using the same fractions, suggest that the selection of products incorporating
aleurone fractions, instead of whole grain, could represent a viable strategy to increase the intake of
bioaccessible and bioavailable phenolics in the framework of a healthy diet. This might or might not
be related to other beneficial effects, which have always been associated with the consumption of
wholemeal cereal products, but evidence is also mounting that aleurone could be equally effective.
Apart from the phenolic compounds, wheat aleurone has been studied for the presence of other
bioactive compounds potentially able to promote a healthy status. For instance, an increase in plasma
betaine was observed after the consumption of both minimally processed aleurone fraction and
aleurone bread in two randomized, controlled, cross-over postprandial studies [22]. The increase was
significantly higher both when the aleurone fraction was compared with another minimally-processed
wheat bran fraction or the control and when the aleurone-rich bread with a white wheat flour bread
control [22]. Moreover, a diet high in wheat aleurone followed by 79 healthy subjects in a parallel,
single-blinded intervention study induced a significantly increased plasma betaine after four weeks
compared to the control group, being also effective in lowering plasma total homocysteine (tHcy) and
LDL cholesterol [23], together with significantly lowering plasma levels of C-reactive protein, which is
an independent risk factor for cardiovascular disease [24].
5. Conclusions
The present work investigated the in vitro bioaccessibility of phenolic acids from a commercial
aleurone-enriched bread compared with a whole grain bread. The results obtained indicate that the
bioaccessibility of the phenolic acids detected in bread samples, with ferulic acid being the most
represented, is higher in the test aleurone-enriched bread, suggesting a potential use of aleurone in the
production of cereal based foods. This represents an attractive opportunity to supply nutritionally
beneficial compounds to the consumers maintaining more acceptable sensory characteristics, including
aspect and taste far from those typical of current wholemeal products.
Future studies in humans should be carried out in order to confirm the data obtained in vitro,
with the final aim of evaluating the bioavailability of phenolic compounds in aleurone-enriched
bread in humans. Finally, further clinical studies should be designed to investigate the effects
of aleurone-enriched bread and other aleurone-based products on health and disease indicators
in humans.
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